Strata Critical Medical (SRTA) Preferred Stock Liabilities (2019 - 2021)

Strata Critical Medical has disclosed Preferred Stock Liabilities across 3 years of filings, most recently posting $225.0 million for Q1 2021.

• In Q1 2021, Preferred Stock Liabilities fell 10.82% year-over-year to $225.0 million; the TTM figure through Mar 2021 stood at $225.0 million (down 10.82% YoY), while the FY2020 annual figure was $226.1 million, changed N/A from the prior year.
• Preferred Stock Liabilities held at $225.0 million in Q1 2021, from $226.1 million in the prior quarter.
• Over the last five years, Preferred Stock Liabilities for SRTA reached as high as $252.3 million in Q1 2020 and fell as low as $225.0 million in Q1 2021.
• The 3-year median for Preferred Stock Liabilities is $244.6 million (2020), against an average of $241.2 million.
• Annual changes were most pronounced in 2020 — Preferred Stock Liabilities grew 0.24% — and 2021, when it fell 10.82%.
• A 3-year view of Preferred Stock Liabilities shows it stood at $246.6 million in 2019, then slipped by 8.32% to $226.1 million in 2020, then slipped by 0.48% to $225.0 million in 2021.
• According to Business Quant data, Preferred Stock Liabilities over the past three periods registered $225.0 million, $226.1 million, and $244.6 million for Q1 2021, Q4 2020, and Q3 2020 respectively.